Signup Crypto ETF Stocks News

Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder - Harmony Biosciences ( NASDAQ:HRMY )

Harmony Biosciences received an FDA Refusal to File letter for pitolisant in idiopathic hypersomnia but plans a Phase 3 trial in Q4 2025. Q4 net product revenue reached $201M, surpassing estimates, with Wakix patient count rising to 7,100, up by 300 sequentially.

Source: www.benzinga.com
February 19, 2025 | 19:24:00
Category: News

What's Going On With BlackRock Stock Today? - BlackRock ( NYSE:BLK )

BlackRock reportedly cancels meetings with companies due to new SEC rules. SEC's stricter regulations on investor activism complicate BlackRock's ability to influence corporate governance. Get real-time earnings alerts before the market moves and access expert analysis that uncovers hidden ...

Source: www.benzinga.com
February 19, 2025 | 19:24:08
Category: News

Precision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment Candidate - Precision BioSciences ( NASDAQ:DTIL )

PBGENE-HBV was safe and well tolerated at 0.2 mg/kg, with no serious adverse events in cohort 1 of the ELIMINATE-B trial. Two of three participants showed a substantial reduction in HBsAg after the first dose, supporting early antiviral activity.

Source: www.benzinga.com
February 19, 2025 | 19:27:24
Category: News

What's Going On With Mullen Automotive Stock Today? - Mullen Automotive ( NASDAQ:MULN )

Mullen Automotive reports a loss per share of $ ( 661.33 ) and defers revenue recognition on invoiced vehicles. Mullen Automotive implements $13M in annual cost cuts, reducing headcount and personnel expenses to improve efficiency.

Source: www.benzinga.com
February 19, 2025 | 17:11:13
Category: News

Ionis Pharmaceuticals Q4 Revenue Growth Exceeds Guidance, Forecasts Over $600 Million In 2025 Sales - Ionis Pharmaceuticals ( NASDAQ:IONS )

Ionis reported Q4 EPS loss of $ ( 0.66 ) , beating estimates, with revenue of $227M, surpassing the $137.6M consensus despite a YoY decline. The company ended 2024 with $2.3B in cash, exceeding guidance, and expects 2025 revenue of over $600M, below consensus.

Source: www.benzinga.com
February 19, 2025 | 17:11:53
Category: News

Better Dividend Stock to Buy for Passive Income Investors: Coca-Cola or Hershey's?

Coca-Cola ( NYSE: KO ) and The Hershey's Company ( NYSE: HSY ) are excellent choices for dividend stock investors.*Stock prices used were the afternoon prices of Feb. 16, 2025. The video was published on Feb. 18, 2025.Continue reading ...

Source: www.fool.com
February 19, 2025 | 17:12:11
Category: News

Appian ( APPN ) Q4 2024 Earnings Call Transcript

APPN earnings call for the period ending December 31, 2024.

Source: www.fool.com
February 19, 2025 | 17:15:13
Category: News

Unpacking the Latest Options Trading Trends in Spotify Technology - Spotify Technology ( NYSE:SPOT )

Investors with a lot of money to spend have taken a bearish stance on Spotify Technology SPOT. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

Source: www.benzinga.com
February 19, 2025 | 17:15:32
Category: News

Market Whales and Their Recent Bets on BMBL Options - Bumble ( NASDAQ:BMBL )

Financial giants have made a conspicuous bullish move on Bumble. Our analysis of options history for Bumble BMBL revealed 10 unusual trades. Delving into the details, we found 70% of traders were bullish, while 30% showed bearish tendencies.

Source: www.benzinga.com
February 19, 2025 | 17:15:38
Category: News

What the Options Market Tells Us About Coinbase Glb - Coinbase Glb ( NASDAQ:COIN )

Deep-pocketed investors have adopted a bullish approach towards Coinbase Glb COIN, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.

Source: www.benzinga.com
February 19, 2025 | 17:15:43
Category: News

© Natavest 2025 - 2026